RxDoctor Payments DataLook up a doctor →

Dawood Sayed, MD

Pain Medicine · Kansas City, KSNPI 1194942219

Payments from drug & device makers

$1,684,280in general payments, 2019–2025

Across 1,172 payments — averaging $1437.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$464K
  • Saluda Medical Americas, Inc.$298K
  • Boston Scientific$143K
  • Mesoblast, Inc.$115K
  • Nalu Medical, Inc.$112K
  • MML US, Inc.$110K
  • plus $442K from 20 others
$72,963in research payments, 2019–2025

Across 12 payments — averaging $6080.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Painteq LLC$55K
  • Saluda Medical Americas, Inc.$16K
  • Nevro Corp.$1K

What the payments were for

  • Consulting fees$344,63053%
  • Speaking & faculty fees$207,50332%
  • Travel & lodging$27,4714%
  • Food & beverage$34,5695%
  • Education$23,1004%
  • Entertainment$640%
  • Ownership interest$12,1332%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,684,280 in reported general payments places this provider in the 95th percentile of 64 pain medicine providers in Kansas.

See all pain medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$279,475
Medicare patients
582
Services billed
2,345

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib95$1,984
Gabapentin103$1,919
Tizanidine Hcl114$1,148
Pregabalin14$833
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen51$539
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen32$267
Meloxicam32$80
Lorazepam18$78
Cephalexin14$61
Topiramate12$41
Tramadol Hcl17$40

Paid to pharmacies, not to this prescriber.

Other pain medicine in Kansas City

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →